A mutation in the translation initiation codon of Gata-1 disrupts megakaryocyte maturation and causes thrombocytopenia

  1. Ian J. Majewski*,,
  2. Donald Metcalf*,,
  3. Lisa A. Mielke*,
  4. Danielle L. Krebs*,
  5. Sarah Ellis§,
  6. Marina R. Carpinelli*,
  7. Sandra Mifsud*,
  8. Ladina Di Rago*,
  9. Jason Corbin*,
  10. Nicos A. Nicola*,
  11. Douglas J. Hilton*, and
  12. Warren S. Alexander*,
  1. *The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050, Australia;
  2. Department of Medical Biology, University of Melbourne, Parkville, Victoria 3010, Australia; and
  3. §Peter MacCallum Cancer Centre, Trescowthick Research Laboratories, St. Andrew's Place, East Melbourne, Victoria 3002, Australia
  1. Contributed by Donald Metcalf, July 27, 2006

Abstract

We have generated mice from a N-ethyl-N-nitrosourea mutagenesis screen that carry a mutation in the translation initiation codon of Gata-1, termed Plt13, which is equivalent to mutations found in patients with acute megakaryoblastic leukemia and Down syndrome. The Gata-1 locus is present on the X chromosome in humans and in mice. Male mice hemizygous for the mutation (Gata-1Plt13/Y) failed to produce red blood cells and died during embryogenesis at a similar stage to Gata-1-null animals. Female mice that carry the Plt13 mutation are mosaic because of random inactivation of the X chromosome. Adult Gata-1 Plt13/+ females were not anemic, but they were thrombocytopenic and accumulated abnormal megakaryocytes without a concomitant increase in megakaryocyte progenitor cells. Gata-1 Plt13/+ mice contained large numbers of blast-like colony-forming cells, particularly in the fetal liver, but also in adult spleen and bone marrow, from which continuous mast cells lines were readily derived. Although the equivalent mutation to Gata-1Plt13 in humans results in production of GATA-1s, a short protein isoform initiated from a start codon downstream of the mutated initiation codon, Gata-1s was not detected in Gata-1 Plt13/+ mice.

Footnotes

  • To whom correspondence may be addressed. E-mail: metcalf{at}wehi.edu.au or alexandw{at}wehi.edu.au
  • Author contributions: I.J.M., D.M., L.A.M., D.L.K., S.E., M.R.C., N.A.N., D.J.H., and W.S.A. designed research; I.J.M., D.M., L.A.M., D.L.K., S.E., M.R.C., S.M., L.D.R., and J.C. performed research; I.J.M., D.M., L.A.M., D.L.K., S.E., M.R.C., D.J.H., and W.S.A. analyzed data; and I.J.M. and W.S.A. wrote the paper.

  • The authors declare no conflict of interest.

  • Abbreviations:
    ENU,
    N-ethyl-N-nitrosourea;
    AML-M7 DS,
    acute megakaryoblastic leukemia and Down syndrome.
« Previous | Next Article »Table of Contents